We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Siemens Healthineers - Laboratory Diagnostics

Provides advanced laboratory diagnostics solutions for the medical industry read more Featured Products: More products

Download Mobile App





Siemens Highlights Presents Latest Breakthroughs in Healthcare

By LabMedica International staff writers
Posted on 03 Feb 2025

Siemens Healthineers (Forchheim, Germany) is presenting its transformative healthcare solutions at Medlab Middle East 2025 that are designed to empower professionals to provide the highest level of care to their patients. More...

Siemens is highlighting various products highlighted including its two new high-volume hematology analyzers, the Atellica HEMA 570 and 580. Designed to meet the hematology testing needs of today’s high-volume labs, both instruments share fast throughput and an identical footprint. Also featured at the event is the IMMULITE 2000 XPi immunoassay system that provides multiple tests on a single, easy-to-use analyzer. This makes it simple to adjust to changes in demand and scale capabilities without disrupting day-to-day operations. Additionally, Siemens is presenting the CN-3000 and CN-6000 coagulation designed to meet the small-sized, mid- and high-volume hemostasis testing solutions. The CN Systems leverage optical testing methodology with intelligent software to automate and standardize sample management for reliable results, reduced repeat testing, and reagent waste. Siemens is also highlighting Atellica Integrated Automation which consolidates revolutionary sample management technology, intelligent software, and IT to provide workflow efficiency with the flexibility to add decapping with little or no additional footprint.

Among its compact solutions featured at the event is the Atellica DCA Analyzer which puts fast, quality HbA1c and ACR results right at the fingertips. Experience the performance and precision you need to improve outcomes. Designed with the speed, standardization, and personalization required to boost efficiencies and meet growing demand, the Atellica DCA Analyzer can be placed wherever it is needed when space is at a premium. Also featured at the event is the RAPIDPoint 500e System that elevates Siemens’ blood gas offering to a new level. This end-to-end blood gas solution reduces the daily burden of device management and enables healthcare professionals to give full care and attention to their patients. Moreover, Siemens is also demonstrating the Atellica VTLi patient-side immunoassay analyzer for high-sensitivity troponin testing at the point of care. It produces accurate results in just 8 minutes, improving ED throughput, reducing stress and strain on acute care clinicians, and aiding in optimizing the use of time and resources of busy laboratories.


New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
New
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.